Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Natulan in advanced Hodgkin lymphoma (ABVD vs standard BEACOPP)
CTR20160433Phase 3Active
- Sponsor
- Leadiant Biosciences
- Start
- Aug 2016
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of procarbazine in classical Hodgkin lymphoma (cHL), sponsored by Leadiant Biosciences. Started Aug 2016; status: active.
02
Drugs
procarbazine
03
Conditions
classical Hodgkin lymphoma (cHL)
Beyond the preview
Go deeper on CTR20160433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160433.